Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
38.8 USD | +4.09% | +9.03% | +35.30% |
Financials (USD)
Sales 2024 * | 4.62M | Sales 2025 * | 3.63M | Capitalization | 6.36B |
---|---|---|---|---|---|
Net income 2024 * | -516M | Net income 2025 * | -562M | EV / Sales 2024 * | 1,073 x |
Net cash position 2024 * | 1.4B | Net cash position 2025 * | 866M | EV / Sales 2025 * | 1,514 x |
P/E ratio 2024 * |
-11.7
x | P/E ratio 2025 * |
-10.9
x | Employees | 378 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.08% |
Latest transcript on Revolution Medicines, Inc.
1 day | +4.09% | ||
1 week | +7.02% | ||
Current month | +4.09% | ||
1 month | +20.40% | ||
3 months | +39.84% | ||
6 months | +95.98% | ||
Current year | +35.30% |
Managers | Title | Age | Since |
---|---|---|---|
Mark Goldsmith
CEO | Chief Executive Officer | 62 | 14-09-30 |
Jack Anders
DFI | Director of Finance/CFO | 47 | 18-07-31 |
Wally Reiher
CTO | Chief Tech/Sci/R&D Officer | - | 15-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Goldsmith
CEO | Chief Executive Officer | 62 | 14-09-30 |
Alexis Borisy
BRD | Director/Board Member | 52 | 14-10-31 |
Sandra Horning
BRD | Director/Board Member | 75 | Nov. 08 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.16% | 0 M€ | 0.00% | - | |
0.12% | 0 M€ | 0.00% | - | |
0.05% | 773 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-01 | 38.8 | +4.09% | 1,439,236 |
24-04-30 | 37.28 | +0.46% | 1,091,846 |
24-04-29 | 37.11 | +3.20% | 1,248,115 |
24-04-26 | 35.96 | +1.78% | 1,213,741 |
24-04-25 | 35.33 | -0.73% | 1,192,512 |
Delayed Quote Nasdaq, May 01, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+35.30% | 6.36B | |
+0.67% | 42.19B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+6.55% | 24.63B | |
-21.66% | 18.2B | |
+29.96% | 12.01B | |
-1.57% | 11.76B | |
+16.03% | 10.4B | |
-4.80% | 9.94B |
- Stock Market
- Equities
- RVMD Stock